GLYFORMIN

This brand name is authorized in Cyprus, Malta, Nigeria, Singapore

Active ingredients

The drug GLYFORMIN contains one active pharmaceutical ingredient (API):

1 Metformin UNII 9100L32L2N - METFORMIN

Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia. Read about Metformin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
GLYFORMIN Film-coated tablet	Υπουργείο Υγείας (CY)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A10BA02	Metformin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BA Biguanides
Discover more medicines within A10BA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: MT	Medicines Authority	Identifier(s): MA084/00901
Country: NG	Registered Drug Product Database	Identifier(s): 04-7968
Country: SG	Health Sciences Authority	Identifier(s): 06937P